← Back to Auro Laboratories Limited Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

AUROLABPharmaceuticals

Auro Laboratories Limited — Financial Ratios & Key Metrics

₹265.00

-2.50%

P/E Ratio71.08xIndustry: 31.77x

ROEN/AReturn on equity

ROCEN/AReturn on capital

Debt/Equity1.01High debt

💎

Valuation & Profitability

P/E Ratio

71.08x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹156.37 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

+29.80%

3 Months

+14.99%

6 Months

-10.06%

1 Year

+23.02%

52W Low

₹159

Current

₹265

52W High

₹317

67% of 52-week range — Mid range

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹267

▼ Price below SMA 50 — Bearish

SMA 200

₹250

▲ Long-term uptrend

Volume Signal

20% of avg

Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

More on Auro Laboratories Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.